Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Discoveries in thrombosis care for medical patients.

Cohen AT.

Semin Thromb Hemost. 2002 Aug;28 Suppl 3:13-7. Review.

PMID:
12232818
3.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
4.

Venous thromboembolic risk and its prevention in hospitalized medical patients.

Haas SK.

Semin Thromb Hemost. 2002 Dec;28(6):577-84. Review.

PMID:
12536351
5.

Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.

Burleigh E, Wang C, Foster D, Heller S, Dunn D, Safavi K, Griffin B, Smith J.

Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S23-9.

PMID:
17032931
6.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
7.

Prophylaxis of venous thromboembolism in medical patients.

Cohen AT, Alikhan R.

Curr Opin Pulm Med. 2001 Sep;7(5):332-7. Review.

PMID:
11584185
9.

Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.

Schädlich PK, Kentsch M, Weber M, Kämmerer W, Brecht JG, Nadipelli V, Huppertz E.

Pharmacoeconomics. 2006;24(6):571-91.

PMID:
16761905
10.

Thromboprophylaxis in medical patients: focus on France.

Bergmann JF, Mouly S.

Semin Thromb Hemost. 2002 Aug;28 Suppl 3:51-5. Review.

PMID:
12232825
11.

State of the art--a journey through the world of antithrombotic therapy.

Turpie AG.

Semin Thromb Hemost. 2002 Aug;28 Suppl 3:3-11. Review.

PMID:
12232817
12.
13.

Rational thromboprophylaxis in medical inpatients: not quite there yet.

Millar JA.

Med J Aust. 2008 Nov 3;189(9):504-6. Review.

PMID:
18976192
14.

Dalteparin: new indication. Prophylaxis in medical patients: no advance.

[No authors listed]

Prescrire Int. 2005 Feb;14(75):14-5.

PMID:
15751168
15.

Postpartum thromboembolism: severe events might be preventable using a new risk score model.

Lindqvist PG, Torsson J, Almqvist A, Björgell O.

Vasc Health Risk Manag. 2008;4(5):1081-7.

16.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

17.
18.
19.

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG; MEDENOX Study.

Arch Intern Med. 2004 May 10;164(9):963-8.

PMID:
15136304
20.

Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.

Kakkar VV.

Semin Hematol. 1997 Oct;34(4 Suppl 4):9-19. Review. No abstract available.

PMID:
9399405
Items per page

Supplemental Content

Write to the Help Desk